Abstract:To the Editor Darier disease (DD; keratosis follicularis; MIM# 124200) is an autosomal dominant skin disorder characterized by warty papules with distribution over seborrheic areas (Burge and Wilkinson, 1992Burge S. Wilkinson D.J. Darier-White disease: a review of the clinical features in 163 patients.J Am Acad Dermatol. 1992; 27: 40-50Abstract Full Text PDF PubMed Scopus (383) Google Scholar). The disease usually presents in the first or second decade of life. Heat, humidity, and UV often exacerbate the symptoms. Recently, the cause of DD was identified to be due to mutations in the ATP2A2 gene on chromosome 12q23–24.1 (Sakuntabhai et al., 1999Sakuntabhai A. Ruiz-Perez V. Carter S. et al.Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease.Nature Genet. 1999; 21: 271-277Crossref PubMed Scopus (616) Google Scholar). A spectrum of missense, nonsense, frameshift, and splicing mutation has since been described in many families with DD (Jacobsen et al., 1999Jacobsen N.J.O. Lyons I. Hoogendoorn B. et al.ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes.Hum Mol Genet. 1999; 8: 1631-1636Crossref PubMed Scopus (125) Google Scholar;Ruiz-Perez et al., 1999Ruiz-Perez V.L. Carter S.A. Healy E. et al.ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class.Hum Mol Genet. 1999; 8: 1621-1630Crossref PubMed Scopus (143) Google Scholar). The ATP2A2 gene encodes sarco-endoplasmic reticulum Ca2+ ATPase type 2 (SERCA2), a Ca2+ pump that plays an important role in intracellular Ca2+ signaling. SERCA2 maintains a low cytosolic Ca2+ concentration by transporting Ca2+ from the cytosol into the lumen of the sarco/endoplasmic reticulum. Evidence for the role of SERCA2 in the formation of the intercellular junction has also been recognized (Stuart et al., 1996Stuart R.O. Sun A. Bush K.T. Nigam S.K. Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores.J Biol Chem. 1996; 271: 13636-13641Crossref PubMed Scopus (102) Google Scholar). Alternative splicing of the ATP2A2 gene produces two isoforms, SERCA2a and SERCA2b, which differ in their carboxy-terminal domains and have distinct tissue expression patterns (Lytton and Maclennan, 1988Lytton J. Maclennan D.H. Molecular cloning of cDNAs from human kidney coding for two alternatively spliced products of the cardiac Ca2+-ATPase gene.J Biol Chem. 1988; 263: 15024-15031Abstract Full Text PDF PubMed Google Scholar). Here we report two novel point mutations in the ATP2A2 gene in two Chinese families with DD. The proband in Family A (proband A; Figure 1) was a 30-y-old male who presented with pruritic, brown, keratotic papules on his face and trunk, reported to have commenced at the age of 15 y. He also had raised keratoses on his palms and soles, beginning at the age of 17 y. The proband in Family B (proband B; Figure 1) was a 40-y-old female who exhibited pruritic warty papules on her trunk. She reported their onset to have occured at age 7 y. Both individuals stated that their skin lesions worsened in summer. All affected members of the two families showed clinic manifestations similar to that of the probands. Blood samples and skin biopsies were obtained after the patients gave informed consent. Genomic DNA was extracted from peripheral blood lymphocytes and each of the 21 exons of the ATP2A2 gene were amplified by polymerase chain reaction (PCR) (primer sequences and conditions previously described;Ruiz-Perez et al., 1999Ruiz-Perez V.L. Carter S.A. Healy E. et al.ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class.Hum Mol Genet. 1999; 8: 1621-1630Crossref PubMed Scopus (143) Google Scholar). PCR-amplified DNA fragments were analyzed using SSCP (single strand conformational polymorphism analysis) to look for abnormal gel migration. Fragments showing altered migration patterns were PCR-purified (Qiagen, Hilden, Germany) and sequenced bi-directionally using an ABI Model 377 automated sequencer. Light microscopic examination of the biopsy material showed focal suprabasal acantholysis and dyskeratotic cells. Electron-microscopic examination suggested aggregated tonofilaments around nuclei and decreased desmosomes on the lateral borders of basal cells. On SSCP, each of the two probands demonstrated extra bands in a single exon. In Family A, the extra band in exon 5 was sequenced and revealed a heterozygous point mutation of G to A at position 445 in exon 5 of the APT2A2 gene. This mutation is expected to cause replacement of the normal aspartic acid by asparagine (D149N) in the resultant protein (Figure 2). The proband from family B was found to have abnormal migration of fragments derived from exon 19. Sequencing of the extra exon 19 band identified by SSCP showed a heterozygous point mutation of C to A at position 2747 in exon19, which changes codon 916 from serine to tyrosine (S916Y) in the resultant protein (Figure 2). These abnormalities were not found in any of the unaffected family members or in 50 unrelated healthy individuals. At least 80 different pathogenic mutations have been identified in the ATP2A2 gene in DD. These include nucleotide substitutions causing missense or nonsense mutations (N = 42), nucleotide substitutions resulting in splice mutations (N = 10), small deletions (N = 20), small insertions (N = 6), gross deletion or gross insertion (N = 2). The missense mutations we describe here, D149N and S916Y, have not been described previously. They affect regions of the protein that encode β strand and transmembrane domains, which have been shown to be highly conserved during evolution, as all known SERCA2 proteins from different species exhibit 100% identity in these domains. The D149N and S916Y mutations may alter the function of these important SERCA2 domains and, as a consequence, impair cell adhesion and differentiation of epidermis. We would like to thank Dr. Sherri J. Bale for critical review.

Successful treatment of Darier's disease with apremilast and review of reported cases

Novel ATP2A2 Gene Mutation c.118G>A Causing Keratinocyte and Cardiomyocyte Disconnection in Darier Disease

Darier Disease: Case Report

Darier disease: Current insights and challenges in pathogenesis and management

Combined Abrocitinib and Acitretin Therapy for Darier's Disease: A Case Report

A Case of Segmental Darier Disease

The use of photodynamic therapy in the management of darier disease and Hailey-Hailey disease: a systematic review

Persistent Cutaneous Lesions of Darier Disease and Second-Hit Somatic Variants in ATP2A2 Gene

Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment

Two Novel Mutations in the ATP2A2 Gene in Chinese Patients with Darier Disease

ALA-PDT combined with 2940nm Ablative Fractional Er:YAG laser for Darier's Disease

Novel Point Mutations of the ATP2A2 Gene in Two Chinese Families with Darier Disease

Darier disease: Histopathology revisited

Two cases of Darier′s disease: ATP2A2 gene mutation analysis and a family survey

Hailey-Hailey disease successfully treated with photodynamic therapy: Case report

Papular acantholytic dyskeratosis of the anogenital area with novel ATP2C1 gene mutations

Identification a Novel Missense Mutation P.r761l in Chinese Patients with Darier’s Disease

Hailey-Hailey Disease Successfully Treated With Adalimumab: A Case Series

Treatment of Hailey-Hailey disease with biologics and small molecule inhibitors: a systematic review

Identification of a novel nonsense ATP2A2 gene variant in a patient with Darier's disease flare following COVID-19 infection: A case report

Protein aggregation of SERCA2 mutants associated with Darier disease elicits ER stress and apoptosis in keratinocytes.